News
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
June 22, 2020
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that dexamethasone could reduce deaths in the severely ill.
News
Large COVID-19 dataset: Kidney injury in >35% of those in hospital
May 20, 2020
The clearest risk factors for the development of AKI were “the need for ventilator support or vasopressor drug treatment.”
![1]()
News
Acute kidney injury in children hospitalized with diarrheal illness in the U.S.
April 29, 2020
Diarrheal illness is the fourth leading cause of death for children younger than 5 years and the fifth leading cause of years of life lost globally.
News
Dapagliflozin trial in CKD halted because of high efficacy
March 30, 2020
An independent data monitoring committee recommended stopping the trial.
![1]()
News
Children with resistant UTIs unexpectedly may respond to discordant antibiotics
January 17, 2020
A low rate of care escalation and high rate of clinical improvement suggest this may be a reasonable approach until urine culture sensitivities return.
![1]()
Article
FDA approves cefiderocol for multidrug-resistant, complicated urinary tract infections
November 15, 2019
The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate.
News
New model for CKD risk draws on clinical, demographic factors
November 8, 2019
The equation has demonstrated high discrimination and variable calibration across a range of populations.
![1]()
News
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
September 30, 2019
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
News
Type of renal dysfunction affects liver cirrhosis mortality risk
September 4, 2019
Patients with acute on chronic kidney disease fared the worst.
![1]()
News
Anticoagulant therapy for AFib in patients with end-stage renal disease
August 23, 2019
Apixaban may be safer than warfarin for patients who have ESRD and who plan for anticoagulation because of AFib.
